'game-changing' coronavirus pill
The health service will reportedly deliver courses of molnupiravir, sometimes referred to as Lagevrio, to clinically vulnerable and and immunosuppressant patients within as little as 48 hours of them testing positive for COVID-19.
Game changer yes, but will it help us as you will need to have had a positive covid test first before it is prescribed?
more info:
News report from the BBC
Comments
-
@MrDJ I wouldn’t feel too bad about not having access to Molnupiravir. The FDA only gave it approval by an exceptionally narrow margin because there was no alternative home pill at the time, however there are far better ones going for approval now. Merck admitted to the FDA its only 30% effective at keeping you out of the hospital, not 50% as originally claimed. Also the method by which it works has alarmed a few infectious disease specialists (it induces a high rate of viral mutation). Both GSK & Pfizer are bringing out their own antiviral pills that work by the more traditional means of stopping viral replication enzymes. Pfizer’s Paxlovid, by the end of December. Pfizer has claimed that it is 89% effective in reducing hospital admission.
Both GSK & Pfizer have a long track record with antivirals.9
1
Categories
- All Categories
- 21 Welcome
- 18 How to use your online community
- 3 Help, Guidelines and Get in Touch
- 11.7K Our Community
- 9.4K Living with arthritis
- 144 Hints and Tips
- 221 Work and financial support
- 754 Chat to our Helpline Team
- 6 Want to Get Involved?
- 393 Young people's community
- 11 Parents of Children with Arthritis
- 38 My Triumphs
- 122 Let's Move
- 31 Sports and Hobbies
- 19 Food and Diet
- 362 Chit chat
- 244 Coronavirus (COVID-19)
- 31 Community Feedback and ideas